# A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

> **NCT05691010** · EARLY_PHASE1 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 28 (estimated)

## Conditions studied

- Endometrial Cancer
- Stage III Endometrial Cancer
- Stage III Endometrial Carcinoma
- Endometrial Carcinoma
- Endometrial Carcinoma Stage III

## Interventions

- **RADIATION:** Intensity-modulated radiation therapy
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT05691010
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-10
- **Primary completion:** 2027-01-10
- **Final completion:** 2027-01-10
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05691010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05691010, "A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05691010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*